Moderna and Merck cancer vaccine used with Keytruda reduces risk of deadly skin cancer spreading
[ad_1] Asbe | Istock | Getty Images Moderna and Merck’s experimental cancer vaccine, used in combination with Merck‘s Keytruda, reduced the risk of the most deadly form of skin cancer spreading to other parts of the body in a clinical trial, according to the midstage trial results published Monday. Moderna and Merck’s cancer vaccine reduced…